Pancreatic Cancer Research

ResearcherUniversity of Yamanashi HospitalActive in the last 2 years

Ryo Saito

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3125-4671; OpenAlex author ID A5003846976. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 3 papers

Papers 4

  1. To Evaluate Whether Pretreatment CA19-9 and DUPAN-2 Levels Can Serve as Predictive Markers to Guide the Choice Between NAT and Upfront Surgery in Pancreatic Ca… Co-author DOI 10.1002/ags3.70140↗
  2. The post-neoadjuvant absolute lymphocyte count reflects the pathological response and local tumor control in pancreatic cancer. Co-author DOI 10.1007/s00595-026-03412-y↗
  3. Prognostic Significance of Extrapancreatic Invasion in Pancreatic Cancer: Excellent Outcomes in Patients With Disease Confined Within the Pancreas. Co-author DOI 10.21873/anticanres.18011↗
  4. Oligo-like liver metastasis: A novel prognostic indicator to improve survival in pancreatic cancer. Co-author DOI 10.1002/ags3.12753↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wataru Izumo · 3 shared papers, 2026 · strength 0.83
  2. Daisuke Ichikawa · 3 shared papers, 2026 · strength 0.83
  3. Hiromichi Kawaida · 3 shared papers, 2026 · strength 0.83
  4. Kazuaki Shimada · 1 shared paper, 2024 · strength 0.24
  5. Satoshi Nara · 1 shared paper, 2024 · strength 0.24
  6. Takeshi Takamoto · 1 shared paper, 2024 · strength 0.24
  7. Daisuke Ban · 1 shared paper, 2024 · strength 0.24
  8. Minoru Esaki · 1 shared paper, 2024 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.